December 11th, 2017
jobs
homes

Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Quidelortho Corp (NQ: QDEL )

29.83 -0.18 (-0.60%)
Streaming Delayed Price Updated: 11:12 AM EDT, Jul 10, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Quidelortho Corp

< Previous 1 2 3 4 5 6 7 Next >
Biotech Stocks are Due for a Rally
There are many rebalancing trades left in your stock portfolio but biotech is in the doldrums. 
Via Talk Markets
Looking for Growth in Small and Mid Cap Life Science Stocks
2021 is an unusual year for biotech with a “blow-off” February high in speculative small caps. 
Via Talk Markets
Quidel Corp (QDEL) Q3 2021 Earnings Call Transcript
QDEL earnings call for the period ending October 4, 2021. 
Via The Motley Fool
Topics Earnings
Exposures Financial
Quidel Corporation to Sponsor Distinguished Speaker Series Conducted by the Bay Area Lyme Foundation
Quidel Corporation to Sponsor Distinguished Speaker Series Conducted by the Bay Area Lyme Foundation 
Via News Direct
Exposures COVID-19
Pediatric Lyme Disease—'An Epidemic Within a Pandemic!’—to be Focus of Free Webinar Hosted by Quidel Corporation Oct. 21
Pediatric Lyme Disease—'An Epidemic Within a Pandemic!’—to be Focus of Free Webinar Hosted by Quidel Corporation Oct. 21 
Via News Direct
Exposures COVID-19 Product Safety
The Daily Biotech Pulse: Merck's Oral COVID-19 Pill Authorized In UK, Novartis Cashes Out Of Roche, Chimerix Plunges On Data, Evotec IPO
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Merck's Oral Antiviral COVID-19 Pill Authorized In UK Merck &... 
Via Benzinga
Exposures COVID-19
Quidel Blows Past Estimates for Q3 Revenue
COVID-19 testing volumes are up again. 
Via The Motley Fool
Exposures COVID-19
The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline
Biotech stocks rose a third week running in the week ending Oct. 29 amid positive reaction to earnings. Big pharma earnings were mostly better than expected. Merck & Co, Inc... 
Via Benzinga
Quidel Clocks Interim Q3 Sales Twice Of Wall Street Expected
Quidel Corporation (NASDAQ: QDEL) announced preliminary estimates for its Q3 revenues are expected to rise between 6% and 7% Y/Y on COVID-19 assay sales. Related:... 
Via Benzinga
Exposures COVID-19
After the Jobs Report, Investors are Looking at The Fed for Tapering Signals
Investors were in wait-and-see mode before the Employment Situation Report and then the volatility hit. Non-farm job growth was expected to be around 500,000... 
Via Benzinga
Topics Economy
Exposures Interest Rates
A Peek Into The Markets: US Stock Futures Edge Higher; All Eyes On Jobs Data
Pre-open movers U.S. stock futures traded slightly higher in early pre-market trade ahead of the all-important jobs report for the month of September. Analysts expect nonfarm... 
Via Benzinga
5 Stocks To Watch For October 8, 2021
Some of the stocks that may grab investor focus today are: At its annual shareholder meeting, Tesla Inc’s (NASDAQ: TSLA) CEO Elon Musk announced plans to move its... 
Via Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
Gainers Vaxart (NASDAQ:VXRT) shares incr... 
Via Benzinga
The Daily Biotech Pulse: Allogene Sinks On FDA Clinical Hold, Takeda Gets Adcom Backing, Quidel Reports Q3 COVID Revenues, IPOs
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 7) Alkermes plc (NASDAQ: ALKS)... 
Via Benzinga
Exposures Product Safety
Employer Demand For Rapid COVID-19 Tests Deepen Shortage In US: Reuters
In recent weeks, an increase in demand for COVID-19 tests from U.S. employers has deepened the shortage of rapid tests and is driving up testing programs costs. What Happened: The... 
Via Benzinga
Exposures COVID-19
2 Growth Stocks to Buy if You're Worried COVID Is Here to Stay
These could be good hedges to help offset the pandemic-related risks. 
Via The Motley Fool
Exposures COVID-19
Biotech Playbook Revisited As Technicals Weaken
Recent breakthroughs with mRNA vaccines over the past two years have shown the enormous potential for transformative therapies. DNA sequencing took off five years ago and new applications are still... 
Via Talk Markets
FDA Establishes Additional Conditions Of Emergency Use Nod For COVID-19 Tests For Viral Mutations
The FDA has issued a letter to establish additional conditions of Emergency Use Authorizations (EUAs) manufacturers of COVID-19 tests. The agency has asked COVID-19... 
Via Benzinga
Exposures COVID-19 Product Safety
Small Cap Biotechs Sagging But More Deals Are Likely to Perk Up the Market
Despite record highs in the Nasdaq recently at the 15,000 level the biotech market seems sluggish. Speculation has ebbed. As if we need a green screen every day. 
Via Talk Markets
Why Shares of Quidel Surged 10% This Week
Demand for its COVID tests are rising with cases. 
Via The Motley Fool
Quidel To Bring OTC COVID-19 Antigen Test To CVS Pharmacy
Quidel Corporation's (NASDAQ: QDEL) non-prescription QuickVue At-Home OTC COVID-19 Test will be available next week at CVS Pharmacy locations across... 
Via Benzinga
Exposures COVID-19
10 Stocks For You To Review
Here are 10 stocks you asked me to analyze. Some are attractive, some are dangerously overvalued and all of them offer teaching points. 
Via Talk Markets
Return on Capital Employed Insights for Quidel
Pulled from Benzinga Pro data Quidel (NASDAQ:QDEL) posted Q2 earnings of $24.33 million, an increase from Q1 of 89.18%. Sales dropped to $176.61 million, a 52.95% decrease between... 
Via Benzinga
The Daily Biotech Pulse: Assembly Bio Halts HBV Study, Moderna Initiates Submission For COVID-19 Booster Dose, FDA Nod For BeiGene, Tiziana Out-Licenses Foralumab
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 1) AbbVie Inc. (NASDAQ: ABBV... 
Via Benzinga
Exposures COVID-19 Product Safety
Healthcare Stocks Hit New Highs but Small Caps Lag
Many smaller cap biotech stocks trade on news and milestones and have no earnings so require more expertise in the field. 
Via Talk Markets
84 Biggest Movers From Friday
Gainers Sphere 3D Corp. (NASDAQ: ANY) shares surged 41.3% to close at $4.86 on Friday after the company inked an agreement with turnkey mining solutions provider Hertford... 
Via Benzinga
Why Quidel Stock Was Falling on Friday
The company's Q2 headline numbers were nowhere near analyst estimates. 
Via The Motley Fool
Topics Earnings
Exposures COVID-19 Financial
55 Stocks Moving In Friday's Mid-Day Session
Gainers Sphere 3D Corp. (NASDAQ: ANY) shares jumped 29.9% to $4.47 after the company inked an agreement with turnkey mining solutions provider Hertford Advisors Ltd to provide a... 
Via Benzinga
Quidel Stock Falls As Q2 Earnings Miss Street Estimates On Lower COVID-19, Influenza Product Sales
Quidel Corporation (NASDAQ: QDEL) reported after the close of the market Thursday that its second-quarter revenues fell 12% Y/Y to $176.6 million, below the consensus... 
Via Benzinga
Topics Earnings
Exposures COVID-19 Financial
Quidel Corp (QDEL) Q2 2021 Earnings Call Transcript
QDEL earnings call for the period ending July 31, 2021. 
Via The Motley Fool
Topics Earnings
Exposures Financial
< Previous 1 2 3 4 5 6 7 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

More ways to get to us

Lethbridge Herald Facebook Facebook
Lethbridge Herald Twitter Twitter
Lethbridge Herald YouTube YouTube

About Us

Contact the Lethbridge Herald

504 - 7th Street South
Lethbridge, AB T1J 3Z7

[P] (403) 328-4411
[F] (403)328-4536

Print Advertising: (403) 328-4410
National Advertising: (403) 380-7585
Online Advertising: (403) 380-7585
Classifieds: (403) 328-4433

© 1996-2017 The Lethbridge Herald, A Division of Continental Newspapers Canada Ltd.